SMAD3 and ovarian cancer: There was no statistical significance in the expression of mRNA for SMAD3, and borderline statistical significance for SMAD2 between the groups of ovarian cancer patients and other subgroups of patients with simple cysts and healthy ovarian tissue (p = 0.709 and p = 0.053, respectively).